Suppr超能文献

突发性聋治疗中的辅助偏头痛药物。

Adjuvant Migraine Medications in the Treatment of Sudden Sensorineural Hearing Loss.

机构信息

Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, California, U.S.A.

Department of Biomedical Engineering, University of California, Irvine, California, U.S.A.

出版信息

Laryngoscope. 2021 Jan;131(1):E283-E288. doi: 10.1002/lary.28618. Epub 2020 Apr 3.

Abstract

OBJECTIVES/HYPOTHESIS: To examine the hearing outcomes of patients with sudden sensorineural hearing loss (SSNHL) treated with oral and intratympanic (IT) steroid only or a combination of steroid and migraine treatment. Our hypothesis was that adjuvant migraine medications may improve outcomes in SSNHL.

METHODS

A retrospective chart review at a tertiary otology center was conducted to identify patients with SSNHL who received oral steroid and IT dexamethasone injection(s) with or without migraine medications (a combination of nortriptyline and topiramate).

RESULTS

A total of 47 patients received oral steroid and IT dexamethasone injection(s) only, and 46 patients received oral steroid and IT dexamethasone injection(s) as well as migraine lifestyle changes plus a combination of nortriptyline and topiramate. There were no significant differences in demographics and baseline audiometric data between the two groups. Both groups demonstrated improvements in pure tone average (PTA) and hearing thresholds at 250 Hz and 8000 Hz posttreatment. However, compared to steroid-only group, the adjuvant migraine medications group had significantly greater improvements in hearing thresholds at the lower frequencies (250 Hz, 500 Hz, 1000 Hz). Patients in the latter cohort also had greater improvement in PTA (P = .01) and received fewer IT injections (P = .04) PTA improvement of ≥ 10 dB was observed in 36 patients (78%) in the adjuvant migraine medications group and 22 patients (46%) in the control group (P < .001).

CONCLUSION

In multimodal treatment of SSNHL, supplementing oral and IT steroid with migraine medications may result in greater improvements in lower frequency hearing thresholds and PTA. Furthermore, adjuvant migraine treatment can lead to decrease in number of IT injections, thus reducing procedure-related risks and complications.

LEVEL OF EVIDENCE

3 Laryngoscope, 131:E283-E288, 2021.

摘要

目的/假设:研究单独使用口服和鼓室内(IT)类固醇或类固醇联合偏头痛治疗治疗突发性感觉神经性听力损失(SSNHL)患者的听力结果。我们的假设是辅助偏头痛药物可能改善 SSNHL 的结果。

方法

在一家三级耳科中心进行回顾性图表审查,以确定接受口服类固醇和 IT 地塞米松注射(加或不加偏头痛药物(曲普坦和去甲替林的组合))的 SSNHL 患者。

结果

共有 47 名患者接受了口服类固醇和 IT 地塞米松注射,46 名患者接受了口服类固醇和 IT 地塞米松注射,以及偏头痛生活方式的改变加上曲普坦和去甲替林的组合。两组在人口统计学和基线听力数据方面没有显著差异。两组在治疗后纯音平均(PTA)和 250 Hz 和 8000 Hz 的听力阈值均有所改善。然而,与仅使用类固醇的组相比,辅助偏头痛药物组在低频(250 Hz、500 Hz、1000 Hz)的听力阈值方面有显著的改善。后者队列中的患者 PTA 也有更大的改善(P =.01),并且接受的 IT 注射更少(P =.04)。在辅助偏头痛药物组中,有 36 名患者(78%)的 PTA 改善≥10dB,而在对照组中只有 22 名患者(46%)(P <.001)。

结论

在 SSNHL 的多模式治疗中,用偏头痛药物补充口服和 IT 类固醇可能会导致低频听力阈值和 PTA 的更大改善。此外,辅助偏头痛治疗可以减少 IT 注射的数量,从而降低与程序相关的风险和并发症。

证据水平

3 级 Laryngoscope,131:E283-E288,2021 年。

相似文献

1
Adjuvant Migraine Medications in the Treatment of Sudden Sensorineural Hearing Loss.
Laryngoscope. 2021 Jan;131(1):E283-E288. doi: 10.1002/lary.28618. Epub 2020 Apr 3.
2
Treatment of Long-term Sudden Sensorineural Hearing Loss as an Otologic Migraine Phenomenon.
Otol Neurotol. 2021 Aug 1;42(7):1001-1007. doi: 10.1097/MAO.0000000000003111.
7
Steroid-based treatments for patients with total sudden sensorineural hearing loss.
Acta Otolaryngol. 2015 Sep;135(9):907-13. doi: 10.3109/00016489.2015.1034881. Epub 2015 Apr 10.
8
[A prospective controlled study on the proper time of intratympanic steroid for profound sudden sensorineural hearing loss of total frequency type].
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Nov 7;53(11):806-810. doi: 10.3760/cma.j.issn.1673-0860.2018.11.002.
9

引用本文的文献

2
Sudden Hearing Loss Waves: The Effect of COVID-19 Infection and Vaccination on the Inner Ear.
Adv Exp Med Biol. 2024;1457:265-283. doi: 10.1007/978-3-031-61939-7_15.
3
White Matter Hyperintensity in Patients with Sudden Sensorineural Hearing Loss.
Diagnostics (Basel). 2024 May 27;14(11):1109. doi: 10.3390/diagnostics14111109.
4
Beyond Vertigo: Vestibular, Aural, and Perceptual Symptoms in Vestibular Migraine.
Curr Pain Headache Rep. 2024 Jul;28(7):633-639. doi: 10.1007/s11916-024-01245-3. Epub 2024 May 23.
5
Google Trends Analysis of Otologic Symptom Searches Following COVID-19.
Iran J Otorhinolaryngol. 2024 May;36(3):475-482. doi: 10.22038/IJORL.2024.75617.3532.
6
Migraine management for the otolaryngologist.
Laryngoscope Investig Otolaryngol. 2023 Jul 6;8(4):1080-1093. doi: 10.1002/lio2.1109. eCollection 2023 Aug.
7
Management of Migraine-Associated Vestibulocochlear Disorders.
Audiol Res. 2023 Jul 19;13(4):528-545. doi: 10.3390/audiolres13040047.
8
A proposed association between subjective nonpulsatile tinnitus and migraine.
World J Otorhinolaryngol Head Neck Surg. 2022 Oct 13;9(2):107-114. doi: 10.1002/wjo2.81. eCollection 2023 Jun.
9
Correlation Between Laterality of Hearing Loss and Migraine Features in Menière's Disease.
Otol Neurotol. 2023 Aug 1;44(7):651-655. doi: 10.1097/MAO.0000000000003925. Epub 2023 Jun 15.
10
Repurposable Drugs That Interact with Steroid Responsive Gene Targets for Inner Ear Disease.
Biomolecules. 2022 Nov 5;12(11):1641. doi: 10.3390/biom12111641.

本文引用的文献

1
Association Between Vestibular Migraine and Migraine Headache: Yet to Explore.
Otol Neurotol. 2020 Mar;41(3):392-396. doi: 10.1097/MAO.0000000000002528.
2
Efficacy of Multi-Modal Migraine Prophylaxis Therapy on Hyperacusis Patients.
Ann Otol Rhinol Laryngol. 2020 May;129(5):421-427. doi: 10.1177/0003489419892997. Epub 2019 Dec 1.
3
Clinical Practice Guideline: Sudden Hearing Loss (Update).
Otolaryngol Head Neck Surg. 2019 Aug;161(1_suppl):S1-S45. doi: 10.1177/0194599819859885.
4
Clinical Practice Guideline: Sudden Hearing Loss (Update) Executive Summary.
Otolaryngol Head Neck Surg. 2019 Aug;161(2):195-210. doi: 10.1177/0194599819859883.
5
Successful treatment of a child with definite Meniere's disease with the migraine regimen.
Am J Otolaryngol. 2019 May-Jun;40(3):440-442. doi: 10.1016/j.amjoto.2019.02.004. Epub 2019 Feb 18.
6
Migraine increases the proportion of sudden sensorineural hearing loss: A longitudinal follow-up study.
Auris Nasus Larynx. 2019 Jun;46(3):353-359. doi: 10.1016/j.anl.2018.10.006. Epub 2018 Oct 30.
7
Plasma levels of endothelial cell-specific molecule-1 and pentraxin-3 in idiopathic sudden sensorineural hearing loss.
J Laryngol Otol. 2018 Nov;132(11):995-999. doi: 10.1017/S002221511800186X. Epub 2018 Oct 29.
8
Evaluating Quality of Life in Patients With Meniere's Disease Treated as Migraine.
Ann Otol Rhinol Laryngol. 2018 Dec;127(12):877-887. doi: 10.1177/0003489418799107. Epub 2018 Sep 9.
9
The Etiological Relationship Between Migraine and Sudden Hearing Loss.
Otol Neurotol. 2017 Dec;38(10):1411-1414. doi: 10.1097/MAO.0000000000001617.
10
Resolution of Persistent Post-Stapedotomy Vertigo With Migraine Prophylactic Medication.
Otol Neurotol. 2017 Dec;38(10):1500-1504. doi: 10.1097/MAO.0000000000001596.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验